[go: up one dir, main page]

TW200801033A - Process for the manufacture of peptide facilitators of reverse cholesterol transport - Google Patents

Process for the manufacture of peptide facilitators of reverse cholesterol transport

Info

Publication number
TW200801033A
TW200801033A TW095138946A TW95138946A TW200801033A TW 200801033 A TW200801033 A TW 200801033A TW 095138946 A TW095138946 A TW 095138946A TW 95138946 A TW95138946 A TW 95138946A TW 200801033 A TW200801033 A TW 200801033A
Authority
TW
Taiwan
Prior art keywords
cholesterol transport
reverse cholesterol
facilitators
peptide
manufacture
Prior art date
Application number
TW095138946A
Other languages
English (en)
Inventor
Jagadish C Sircar
James J Mencel
Original Assignee
Avanir Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avanir Pharmaceuticals filed Critical Avanir Pharmaceuticals
Publication of TW200801033A publication Critical patent/TW200801033A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
TW095138946A 2005-11-04 2006-10-23 Process for the manufacture of peptide facilitators of reverse cholesterol transport TW200801033A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73335205P 2005-11-04 2005-11-04

Publications (1)

Publication Number Publication Date
TW200801033A true TW200801033A (en) 2008-01-01

Family

ID=37907410

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095138946A TW200801033A (en) 2005-11-04 2006-10-23 Process for the manufacture of peptide facilitators of reverse cholesterol transport

Country Status (4)

Country Link
US (1) US20070105783A1 (zh)
AR (1) AR056766A1 (zh)
TW (1) TW200801033A (zh)
WO (1) WO2007055873A2 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2855464B1 (en) * 2012-05-31 2016-10-26 Theravance Biopharma R&D IP, LLC Nitric oxide donor neprilysin inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2052595T3 (es) * 1986-12-15 1994-07-16 Inst Nat Sante Rech Med Nuevos derivados peptidicos y su aplicacion en especial en terapeutica.
US4952562A (en) * 1989-09-29 1990-08-28 Rorer Pharmaceutical Corporation Anti-thrombotic peptides and pseudopeptides
AU8334298A (en) * 1997-07-15 1999-02-10 Novo Nordisk A/S Nociceptin analogues
US6821774B1 (en) * 1999-06-18 2004-11-23 Cv Therapeutics, Inc. Compositions and methods for increasing cholesterol efflux and raising HDL using ATP binding cassette transporter ABC1
US7148197B2 (en) * 2000-08-24 2006-12-12 The Regents Of The University Of California Orally administered small peptides synergize statin activity
US6664230B1 (en) * 2000-08-24 2003-12-16 The Regents Of The University Of California Orally administered peptides to ameliorate atherosclerosis
FR2820435B1 (fr) * 2001-02-05 2004-02-27 Genfit S A Procedes d'identification de composes modulant le transport inverse du cholesterol
JP4010951B2 (ja) * 2001-05-15 2007-11-21 大正製薬株式会社 アルギニン誘導体
AU2004233333A1 (en) * 2003-04-22 2004-11-04 Avanir Pharmacueticals Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
WO2006049597A1 (en) * 2004-10-27 2006-05-11 Avanir Pharmaceuticals Amino acid-derived compounds as modulators of the reverse cholesterol transport

Also Published As

Publication number Publication date
WO2007055873A2 (en) 2007-05-18
AR056766A1 (es) 2007-10-24
WO2007055873A3 (en) 2007-10-18
US20070105783A1 (en) 2007-05-10

Similar Documents

Publication Publication Date Title
GB0412753D0 (en) Pharmaceutical compositions for the treatment of disease and/or symptoms in arthritis
MX2009005460A (es) (s)-n-estereoisomeros de analogos de 7,8-saturados-4,5-epoxi-morfi nano.
ZA200800464B (en) Peptides for use in the treatment of obesity
IL185462A0 (en) New pharmaceutical compositions useful in the treatment of pain
IL191057A0 (en) Novel 2-amino-heterocycles useful in the treatment of abeta-related pathologies
LT1854477T (lt) Peptidai, slopinantys plazmos kalikreiną, skirti naudoti oftalmologinių sutrikimų gydymui
WO2006116716A3 (en) Materials and methods for enhanced degradation of mutant proteins associated with human disease
SG10201407403UA (en) Treatments For Gastrointestinal Disorders
IL196565A0 (en) Physiologically active polypeptide polymer micelle having protein enclosed therein and process for the production thereof
PT2078038E (pt) Agentes tensioativos reconstituídos apresentando propriedades melhoradas
IL189104A (en) Pharmaceutical preparation containing lasalazide or sodium balasalazide for use in the treatment of gastrointestinal disorders.
IL189270A0 (en) Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
EP1773369A4 (en) PHARMACEUTICAL COMPOSITIONS AND METHOD FOR THE PEPTIDE TREATMENT
EP1922345A4 (en) PROCESS FOR THE PREPARATION OF COPOLYMER-1
TW200503747A (en) Peptide mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
TW200602042A (en) Heterocyclic derivatives for treatment of hyperlipidemia and related diseases
WO2007111661A3 (en) Human antibodies specific for gastrin materials and methods
MY145406A (en) Composition for preventing or treating damages of the mucosa in the gastrointestinal tracts
EP1834624A4 (en) MEDICAL COMPOSITION AND MANUFACTURING METHOD THEREFOR
TW200801033A (en) Process for the manufacture of peptide facilitators of reverse cholesterol transport
WO2006020430A8 (en) Novel composition and methods for the treatment of immune related disease
IL195901A0 (en) Viral capsid proteins and any peptides or compositions thereof for the treatment of pathologic disorders
TW200603794A (en) Small molecules for treatment of hypercholesterolemia and related diseases
GB0616061D0 (en) Peptides and uses thereof
TW200603795A (en) Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia